10 completed, 2 unknown, 1 terminated, 1 withdrawn. 14 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 10, Unknown 2, Terminated 1, Withdrawn 1 |
Follow Hematologic Tests: new trials by email Literature Review of Hematologic Tests trials Research Report on Hematologic Tests
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 18 | 2023-03-06 | 2025-01-15 |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 14 | 2022-07-17 | 2025-01-07 |
| KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) IMP Application KM-001, Chemistry, Hematology - Lichen Simplex Chronicus | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 55 | 2022-05-24 | 2024-04-02 |
| Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy Levomethadone HCl, Methadone, Morphine Sulfate - Opioid Use Disorder, Moderate | Phase 1 | Withdrawn | Lyndra Inc. | 2022-02-28 | 2023-01-19 | |
| Study of Codivir in Patients With COVID-19 Covidir injections, One Step Test, IgM and IgG dosage - Covid19 | Phase 1 | Completed | Code Pharma | 12 | 2021-03-29 | 2021-11-02 |
| Next Generation Personalized Neuroblastoma Therapy Biopsy, Next Generation Sequencing, Tumor Scans - Neuroblastoma, Cancer | Phase 1 | Terminated | Yael P Mosse | 66 | 2016-07-01 | 2026-03-10 |
| Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination Blood test (PSA) - Prostate Cancer | Phase 1 | Unknown | Kaplan Medical Center | 60 | 2016-05-01 | 2016-04-21 |
| Personalized Medicine for Diabetes Prediction and Prevention of Complications Breath analysis and blood analysis - Metabolic Syndrome, Diabetes | Phase 1 | Unknown | Rambam Health Care Campus | 60 | 2011-02-01 | 2010-12-31 |
| Neulasta in Type 1 Diabetes Neulasta (Pegylated), Placebo, Mixed Meal Tolerance Test (MMTT) - Type 1 Diabetes | Phase 1 | Completed | University of Florida | 21 | 2008-04-01 | 2015-04-09 |
| Metabolism of Nicotine and Cotinine in Pregnant African-American Women Blood testing - Pregnancy, Smokers | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 50 | 2005-01-06 | 2017-07-02 |
| Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) Blood Test, Urine Test, Physical Exam - Healthy | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2004-12-09 | 2017-07-02 |
| Family Management of Childhood Diabetes Study Blood testing - Diabetes, Type 1 Diabetes | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1298 | 2004-11-08 | 2019-12-17 |
| Anthrax Vaccine Clinical Trials Anthrax Vaccine, Blood Chemistry, Hematology - Anthrax | Phase 1 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 93 | 2004-09-08 | 2017-07-02 |
| Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection Indinavir, Zidovudine, Lamivudine - HIV Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 42 | 1997-03-03 | 2017-07-02 |
Coronavirus Infections (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Keratosis palmoplantaris papulosa (2) · Pachyonychia Congenita (2) · Anthrax (1) · COVID-19 (1) · HIV Infections (1) · Immunologic Deficiency Syndromes (1) · Lymphoma, Follicular (1) · Metabolic Syndrome (1) · Neoplasms (1) · Neuroblastoma (1) · Neurodermatitis (1) · Opioid-Related Disorders (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3) · Orvida Pharma (formerly Kamari Pharma) (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Code Pharma (1) · Kaplan Medical Center (1) · Lyndra Inc. (1) · Rambam Health Care Campus (1) · University of Florida (1) · Yael P Mosse (1)
United States (7) · Israel (3) · Brazil (1) · Germany (1) · United Kingdom (1)
Clay W. Mash, Ph.D. (1) · Eddy Karnieli, MD (1) · Eynat Finkelshtein (1) · John M Maris, MD (1) · Michael J Haller, MD (1) · Richard Scranton, MD, MPH (1) · Tonja R. Nansel, Ph.D. (1)
4UH3DA050310-02 (1), R21DK078863 (1)